• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 27 of 100
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
Commentary
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
By Mark Dybul and Serhat GümrükçüDecember 1, 2021
The most important meeting yet for global pandemic response—and drugmakers
Commentary
The most important meeting yet for global pandemic response—and drugmakers
By Nicole Hassoun and Kaushik BasuNovember 29, 2021
To avoid the superbug pandemic, we must fix the business model for new antibiotics
Commentary
To avoid the superbug pandemic, we must fix the business model for new antibiotics
By Michelle McMurry-Heath and Henry SkinnerNovember 25, 2021
DeepMind and now Isomorphic Laboratories CEO Demis Hassabis
Tech
DeepMind spins out new Alphabet company focused on drug discovery
By Jeremy KahnNovember 4, 2021
Riding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead
Features
Riding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead
By Erika FryOctober 30, 2021
COVID-19 experimental antiviral drug MOLNUPIRAVIR, two white pills with letters engraved on side, potential experimental WHO Coronavirus cure, pandemic outbreak crisis, isolated on blue background
Health
Merck says poorer countries can produce its new COVID pill without paying royalties
By David MeyerOctober 27, 2021
Robots work in a warehouse
Newsletters
What’s big in A.I. this year
By Jeremy KahnOctober 12, 2021
Merck asks FDA to authorize its breakthrough COVID antiviral pill
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By Matthew Perrone and The Associated PressOctober 11, 2021
AstraZeneca says antibody drug is effective at stopping mild COVID-19 from worsening
Health
AstraZeneca says antibody drug is effective at stopping mild COVID-19 from worsening
By Suzi Ring and BloombergOctober 11, 2021
Merck's antiviral pill for COVID-19
Health
Everything to know about Merck’s COVID antiviral pill
By Emily MullinOctober 5, 2021
CVS Health is about to turn hundreds of its drugstores into health care super-clinics
Health
CVS Health is about to turn hundreds of its drugstores into health care super-clinics
By Shawn TullyOctober 4, 2021
Pfizer vaccine
Health
What comes next for COVID booster shots after the FDA panel hedges on Pfizer
By Sy MukherjeeSeptember 17, 2021
Kids at school in masks
Health
3 things you should know about the timeline for kids’ COVID vaccines
By Sy MukherjeeSeptember 16, 2021
White House unveils plan to lower prescription drug prices
Politics
White House unveils plan to lower prescription drug prices
By Chris MorrisSeptember 9, 2021
Parkinson's lab grown synthetic mini brain
Health
Parkinson’s disease has no approved treatment. Scientists want to use lab grown mini-brains to change that
By Sy MukherjeeSeptember 8, 2021
1...
  • 25
  • 26
  • 27
  • 28
  • 29
...100
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
'Skills nobody can take': Meet a 20-year-old with a 4.5 GPA who skipped college for technical school to land an 'AI-proof' careerplaceholder alt text
By Muskaan ArshadSeptember 22, 2026
Middle East
China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment schemeplaceholder alt text
By Jason MaSeptember 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.